AI assistant
Sending…
BioCardia, Inc. — Director's Dealing 2018
Mar 22, 2018
35081_dirs_2018-03-22_b6f28b3a-f744-49ff-83da-fc32ea2dcccb.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BioCardia, Inc. (BCDA)
CIK: 0000925741
Period of Report: 2018-03-21
Reporting Person: McClung David (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-21 | Common Stock | P | 750 | $1.90 | Acquired | 750 | Direct |
More from BioCardia, Inc.
Capital/Financing Update
2026
Jun 8
Regulatory Filings
2026
Jun 5
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 21
Earnings Release
2026
May 15
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 20
Delisting Announcement
2026
Apr 15